Driving breakthrough discoveries for better healthcare outcomes.
Explore SPARC’s work in action, including panel discussions, articles, and more.
Collaboration across the rare disease community has driven major breakthroughs in diagnosis and treatment. Innovative, data-driven approaches pioneered in this field are now shaping a new model for medical research—one that could improve outcomes and reduce costs across all diseases.
Achieving health equity requires centering communities in biomedical research. This panel explores how collaboration across sectors can empower communities to shape research and drive lasting change.
This 2024 Future of Health panel explores how lifestyle choices and early screening can help prevent neurodegenerative diseases, alongside new advances in dementia diagnostics and treatments.
Mental illness affects one in eight people worldwide, driving global efforts to improve understanding, diagnosis, and treatment. New approaches targeting brain circuits are paving the way for more precise, personalized therapies and innovative solutions for mental health care.
As genetic research advances, questions remain about how this knowledge translates into better treatments and care. This panel examines successes, challenges, and future directions in using genetics to inform medicine.
SPARC conducted a landscape analysis of health equity in science to identify where philanthropy can drive meaningful change. The Giving Smarter Guide outlines key trends, barriers, and opportunities to advance more equitable research and health outcomes.
Collaboration and community are vital in tackling rare diseases like sarcoidosis. This piece highlights how new initiatives are connecting researchers, patients, and funders to drive progress.
A new SPARC report, commissioned by The 10,000 Brains Project, highlights how AI and precision medicine can transform neurodegenerative disease research.
Neurodegenerative diseases affect over 50 million people worldwide. In partnership with the 10,000 Brains Project, SPARC mapped how AI and precision medicine can transform research and accelerate progress toward better treatment.
LHON causes sudden, irreversible blindness. SPARC’s partnership with the LHON Collective and the Giving Smarter Guide highlights how philanthropy can accelerate research, foster collaboration, and drive progress toward treatments that restore vision and improve lives.
There are no treatments to prevent or reverse LHON vision loss. SPARC’s Giving Smarter Guide shows how philanthropy can drive progress toward new discoveries.